Sleep and circadian dysfunction in neurodegenerative disorders: Insights from a mouse model of Huntington's disease

Minerva Pneumologica

Volumn 51, Issue 3, 2012, Pages 93-106

  Kuljis, D ^a   Schroeder, A M ^a   Kudo, T ^a   Loh, D H ^a   Willison, D L ^a   Colwell, C S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Circadian rhythm; Huntington disease; Sleep; Suprachiasmatic nucleus

Indexed keywords

BRAIN REGION; CARDIOVASCULAR SYSTEM; CIRCADIAN RHYTHM; CIRCADIAN RHYTHM SLEEP DISORDER; DEGENERATIVE DISEASE; DISEASE COURSE; GENE EXPRESSION REGULATION; HUMAN; HUNTINGTON CHOREA; MOLECULAR CLOCK; NEGATIVE FEEDBACK; NERVE CELL; NONHUMAN; OSCILLATION; REVIEW; SUPRACHIASMATIC NUCLEUS;

EID: 84869205148     PISSN: 00264954     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (126)

1. Leger D, Guilleminault C, Dreyfus JP, Delahaye C, Paillard M. Prevalence of insomnia in a survey of 12 778 adults in France. J Sleep Res 2000;9:32-42.
2. Hossain JL, Shapiro CM. The prevalence, cost implications, and management of sleep disorders: an overview. Sleep Breath 2002;6:85-102. (Pubitemid 34752701)
3. Luckhaupt SE, Tak SW, Calvert GM. The prevalence of short sleep duration by industry and occupation in the National Health Interview Survey. Sleep 2010;33:149-59.
4. Durmer JS, Dinges DF. Neurocognitive consequences of sleep deprivation. Semin Neurol 2005;25:117-29. (Pubitemid 40471632)
5. Mullington JM, Haack M, Toth M, Serrador JM, Meier-Ewert HK. Cardiovascular, inflammatory, and metabolic consequences of sleep deprivation. Prog Cardiovasc Dis 2009;51:294-302.
6. Cohen S, Doyle WJ, Alper CM, Janicki-Deverts D, Turner RB. Sleep habits and susceptibility to the common cold. Arch Intern Med 2009;169:62-7.
7. Moldofsky, H, Luk WP, Dickstein J. Sleep, health and immunoscompetence. Neuroimmune Biology 2001;1:255-68.
8. Foley D, Ancoli-Israel S, Britz P, Walsh J. Sleep disturbances and chronic disease in older adults: results of the 2003 National Sleep Foundation Sleep in America survey. J Psychosom Res 2004;56:497-502. (Pubitemid 38686688)
9. Prinz PN, Vitaliano PP, Vitiello MV, Bokan J, Raskind M, Peskind E et al. Sleep, EEG and mental functioni changes in senile dementia of the Alzheimer's type. Neurobiol Aging 1982;3:299-309.
10. Morton A, Wood N, Hastings M, Hurelbrink C, Barker R, Maywood E. Disintegration of the sleep-wake cycle and circadian timing in Huntington's disease. J Neurosci 2005;25:157-63. (Pubitemid 40110776)
11. Partinen M. Sleep disorder related to Parkinson's disease. J Neurol 1997;244 (Suppl 1).S3-6. (Pubitemid 27156787)
12. Iranzo A, Santamaria J, Serradell M, Marti MJ, Valldeoriola F, Tolosa E. Rapid-eye-movement sleep behaviour disorder as an early marker for a neurodegenerative disorder: a descriptive study. Lancet Neurol 2006;5:572-7. (Pubitemid 43867426)
13. Julein C, Thompson J, Wild S, Yardumian P, Snowden J, Turner G, Craufurd D. Psychiatric diorders in preclinical Huntington's disease. J Neurol Neurosurg Psychiatry 2007;78:939-43. (Pubitemid 47310828)
14. Dibner C, Schibler U, Albrecht U. The mammalian circadian timing system: organization and coordination of central and peripheral clocks. Annu Rev Physiol 2010;72:517-49.
15. Mohawk JA, Takahashi JS. Cell autonomy and synchrony of suprachiasmatic nucleus circadian oscillators. Trends Neurosci 2011;34:349-58.
16. Albrecht U, SunZS, Eichele G, Lee CC. A differential response of two putative mammalian circadian regulators, mper1 and mper2, to light. Cell 1997;91:1055-64. (Pubitemid 28027837)
17. Shearman LP, ZYlka MJ, Weaver DR, Kolakowski LF Jr, Reppert SM. Two period homologs: circadian expression and photic regulation in the suprachiasmatic nuclei. Neuron 2007;19:1261-9.
18. Sun ZS, Albrecht U, Zuchenko O, Bailey J, Eichele G, Lee CC. RIGUI, a putative mammalian ortholog of the Drosophila period gene. Cell 1997;90:1003-11. (Pubitemid 27408514)
19. Tei H, Okamura H, Shigeyoshi Y, Fukuhura C, Ozawa R, Hirose M et al. Circadian oscillation of a mammalian homologue of the Drosophila period gene. Nature 1997;389:512-6. (Pubitemid 27435329)
20. van der Horst GT, Muijtjens M, Kobayashi K, Takano R, Kanno S, Takao M, de Wit J et al. (1999). Mammalian Cry1 and Cry2 are essential for maintenance of circadian rhythms. Nature 1999;398;627-30. (Pubitemid 29183691)
21. Gekakis N, Staknis D, Nguyen H, Davis FC, Wilsbacher L, King D, Takahashi JS et al. Role of the CLOCK Protein in the Mammalian Circadian Mechanism. Science 1998;280:1564-9. (Pubitemid 28277694)
22. Hogenesch JB, Gu YZ, Jain S, Bradfield CA. The basic-helix-loop-helix-PAS orphan MOP3 forms transcriptionally active complexes with circadian and hypoxia factors. Proc Natl Acad Sci U S A 1998;95:5474-9. (Pubitemid 28224118)
23. Takahata S, Sogawa K, Kobayashi A, Ema M, Mimura J, Ozaki N et al. Transcriptionally Active Heterodimer Formation of an Arnt-like PAS Protein, Arnt3, with HIF-1a, HLF, and Clock. Biochem Biophys Res Commun 1998; 794(248), 789-794. (Pubitemid 28404501)
24. Thresher RJ, Vitaterna MH, Miyamoto Y, Kazantsev A, Hsu DS, Petit C et al. Role of mouse cryptochrome blue-light photoreceptor in circadian photoresponses. Science 1998;282:1490-4. (Pubitemid 28538611)
25. Siepka SM, Yoo SH, Park J, Song W, Kumar V, Hu Y et al. Circadian mutant Overtime reveals F-box protein FBXL3 regulation of cryptochrome and period gene expression. Cell 2007;129:1011-23. (Pubitemid 46802705)
26. Duong HA, Robles MS, Knutti D, Weitz CJ. A molecular mechanism for circadian clock negative feedback. Science 2011;332:1436-9.
27. Busino L, Bassermann F, Maiolica A, Lee C, Nolan PM, Godinho SI et al. SCFFbx13 controls the oscillation of the circadian clock by directing the degradation of cryptochrome proteins. Science 2007;316:900-4. (Pubitemid 46764282)
28. Godinho SI, Maywood ES, Shaw L, Tucci V, Barnard AR, Busino L et al. The afterhours mutant reveals a role for Fbx13 in determining mammalian circadian period. Science 2007;316:897-900. (Pubitemid 46764281)
29. Gallego M, Virshup DM. Post-translational modifications regulate the ticking of the circadian clock. Nat Rev Mol Cell Biol 2007;8:139-48. (Pubitemid 46432533)
30. Lee C, Etchegaray JP, Cagampang FRA, Loudon ASI, Reppert S. Posttranslational mechanisms regulate the mammalian circadian clock. Cell 2001;107:855-67. (Pubitemid 34084977)
31. Harms E, Kivimae S, Young, MW, Saez L. Posstranscriptional and postrranslational regulation of clock genes. J Biol Rhyths 2004;19:361-73. (Pubitemid 39238205)
32. Preitner N, Damiola F, Lopez-Molina L, Zakany J, Duboule D, Albrecht U et al. The orphan nuclear receptor REVERB alpha controls circadian transcription within the positive limb of the mammalian circadian oscillator. Cell 2002;110:251-60. (Pubitemid 34876552)
33. Sato F, Kawamoto T, Fujimoto K, Noshiro M, Honda KK, Honma S et al. Functional analysis of the basic helix-loop-helix transcription factor DEC1 in circadian regulation. Interaction with BMAL1. Eur J Biochem 2004;271:4409-19. (Pubitemid 39576558)
34. Crumbley C, Wang Y, Kojetin DJ, Burris TP. Characterization of the core mammalian clock component, NPAS2, as a REV-ERBalpha/RORalpha target gene. J Biol Chem 2010;285:35386-92.
35. Crumbley C, Burris TP. Direct regulation of CLOCK expression by REV-ERB. PLoS One. 2011;6:el7290.
36. Panda S, Antoch MP, Miller BH, Su AI, Schook AB, Straume M et al. Coordinated transcription of key pathways in the mouse by the circadian clock. Cell 2002;109:307-20. (Pubitemid 34606874)
37. Storch KF, Lipna OIL, Viswanathan N, Davis F, Wong W, Weitz C. Extensive and divergent circadian gene expression in liver and heart. Nature 2002;417:78-83. (Pubitemid 34498819)
38. Hogenesch JB, Panda S, Kay S, Takahashi JS. Circadian transcriptional output in the SCN and liver of the mouse. Novartis Found Symp 2003;253:171-80.
39. Baggs JE, Hogenesch JB. Genomics and systems approaches in the mammalian circadian clock. Curr Opin Genet Dev 2010;20:581-7.
40. Kornmann B, Schaad O, Bujard H, Takahashi JS, Schibler U. System-driven and oscillator-dependent circadian transcription in mice with a conditionally active liver clock. PLoS Biol 2007;5:e34.
41. Lejeune-Lenain C, Van Cauter E, Désir D, Beyloos M, Frackson JR. Control of circadian and episodic variations of adrenal androgens secretion in man. J Endocrinol Invest 1987;10:267-76. (Pubitemid 17097631)
42. Deery MJ, Maywood ES, Chesham JE, Sladek M, Karp NA, Green EW et al. Proteomic analysis reveals the role of synaptic vesicle cycling in sustaining the suprachiasmatic circadian clock. Curr Biol 2009;19:2031-6.
43. Reddy AB, Karp NA, Maywood ES, Sage EA, Deery M, O'Neill JS et al. Circadian orchestration of the hepatic proteome. Curr Biol 2006;16:1107-15. (Pubitemid 43815745)
44. Welsh DK, Takahashi JS, Kay SA. Suprachiasmatic nucleus: cell autonomy and network properties. Annu Rev Physiol 2010;72:551-77.
45. Van den Pol AN. The hypothalamic suprachiasmatic nucleus of rat: intrinsic anatomy. J Comp Neurol 1980;191:661-702. (Pubitemid 10086258)
46. Antle MC, Smith VM, Sterniczuk R, Yamakawa GR, Rakai BD. Physiological responses of the circadian clock to acute light exposure at night. Rev Endocr Metab Disord 2009;10:279-91.
47. Golombek DA, Rosenstei RE. Physiology of circadian entrainment. Physiol Rev 2010;90:1063-102.
48. Morin LP, Allen CN. The circadian visual system, 2005. Brain Res Rev 2006;51:1-60. (Pubitemid 44218910)
49. Hamada T, Antle MC, Silver R. Temporal and spatial expression patterns of canonical clock genes and clock-controlled genes in the suprachiasmatic nucleus. Eur J Neurosci 2004;19:1741-8. (Pubitemid 38482562)
50. Nakamura W, Yamazaki S, Takasu NN, Mishima K, Block GD. Differential response of Period 1 expression within the suprachiasmatic nucleus. J Neurosci 2005;25:5481-7. (Pubitemid 40800640)
51. Yan L, Okamura H. Gradients in the circadian expression of Per1 and Per2 genes in the rat suprachiasmatic nucleus. Eur J Neurosci 2002;15:1153-62. (Pubitemid 35463616)
52. Antle MC, Silver R. Orchestrating time: arrangements of the brain circadian clock. Trends Neurosci 2005;18:145-51. (Pubitemid 40320760)
53. Abrahamson EE, Moore RY. Suprachiasmatic nucleus in the mouse: retinal innervations, intrinsic organization and efferent projections. Brain Res 2001;6:172-91. (Pubitemid 32971919)
54. Kriegsfeld LJ, Leak RK, Yackulic CB, LeSauter J, Silver R. Organization of suprachiasmatic nucleus projections in Syrian hamsters (Mesocricetus auratus): an anterograde and retrograde analysis. J Comp Neurol 2004;468:361-79. (Pubitemid 37549656)
55. Kalsbeek A, Palm IF, La Fleur SE, Scheer FAJL, Perreau-Lenz S, Ruiter M et al. SCN outputs and the hypothalamic balance of life. J Biol Rhythms 2006;21:458-69. (Pubitemid 44706827)
56. Deboer T, Vansteensel MJ, Detari L, Meijer JH. Sleep states alter activity of suprachiasmatic nucleus neurons. Nature Neuroscience 2003,6:1086-90. (Pubitemid 37186201)
57. Meijer JH, Schaap J, Watanabe K, Albus H. Multiunit activity recordings in the suprachiasmatic nuclei: in vivo versus in vitro models. Brain Research 1997;753:322-7. (Pubitemid 27151879)
58. Yamazaki S, Kerbeshian MC, Hocker CG, Block GD, Menaker M. Rhythmic properties of the hamster suprachiasmatic nucleus in vivo. J Neurosci 1998;18:10709-23. (Pubitemid 29016588)
59. Schaap J, Meijer JH. Opposing effects of behavioral activity and light on neurons of the suprachiasmatic nucleus. Eur J Neurosci 2001;13:1955-62. (Pubitemid 32537222)
60. Huntington's Disease Collaborative Research Group. A novel gene containing a trinucleuotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 1993;72:971-83.
61. Bonelli RM, Beat MF. Huntington's disease. Handb Clin Neurol 2012;106:507-26.
62. Margolis RL, Ross CA. Diagnosis of Huntington disease. Clin Chem 2003;49:1726-32. (Pubitemid 37194241)
63. Schulte J, Littleton JT. The biological function of the Huntingtin protein and its relevance to Huntington's Disease pathology. Curr Trends Neurol 2011;5:65-78.
64. Petersén A, Gil J, Maat-Schieman M, Björkqvist M, Tanila H, Araújo I et al. Orexin loss in Huntington's disease. Hum Mol Genet 2005;14:39-47. (Pubitemid 40123461)
65. Aziz NA, Pijl H, Frolich M, Schroder-van der Elst JP, van der Bent C, Roelfsema F et al. Growth hormone and ghrelin secretion are associated with clinical severity in Huntington's disease. Eur J Neurol 2010;17:280-8.
66. Petersén A, Hult S, Kirik D. Huntington's disease - new perspectives based on neuroendocrine changes in rodents models. Neurodegener Dis 2009;6:154-64.
67. Kremer H, Roos R, Dingjan G, Marani E, Bots G. Atrophy of the hypothalamic lateral tuberal nucleus in Huntington's disease. J Neuropathol Exp Neurol 1990;49:371-82. (Pubitemid 20207798)
68. Lavin P, Bone I, Sheridan P. Studies of hypothalamic function in Huntington's chorea. J Neurol Neurosurg Psychiatry 1981;44:414-8. (Pubitemid 11046277)
69. Wood NI, Goodman AO, van der Burg JM, Gazeau V, Brundin P, Bjorkqvist M et al. Increarsed thirst and drinking in Huntington's disease and the R6/2 mouse. Brain Res Bull 2008;76:70-9.
70. Hinton SC, Paulsen JS, Hoffmann RG, Reynolds NC, Zimbelman JL, Rao SM. Motor timing variability increases in preclinical Huntington's disease patients as estimated onset of motor symptoms approaches. J Int Neuropsychol Soc 2007;13:539-43. (Pubitemid 47307494)
71. Paulsen JS, Langbehn DR, Stout JC, Aylward E, Ross CA, Nance M et al. Predict HD investigators and coordinators of the Huntington Study Group Detection of Huntington's disease decades before diagnosis: The Predict HD study J Neurol Neurosurg Psychiatry 2008;79:874-80.
72. Videnovic A, Leurgans S, Fan W, Jaglin J, Shannon KM. Daytime somnolence and nocturnal sleep disturbances in Huntington disease. Parkinsonism Relat Disord 2009;15:471-4.
73. Duff K, Paulsen JS, Beglinger LJ, Langbehn DR, Stout JC. Predict-HD Investigators of the Huntington Study Group Psychiatric symptoms in Huntingto's disease before diagnosis: the Predict-HD study Biol Psychiatry 2007;62:1341-6. (Pubitemid 350180721)
74. Soneson C, Fontes M, Zhou Y, Denisov V, Paulsen JS, Kirik D et al.; Huntington Study Group PREDICT-HD investigators. Early changes in the hypothalamic region in prodromal Huntington disease revealed by MRI analysis. Neurobiol Dis 2010;40:531-43.
75. Peavy GM, Jacobson MW, Goldstein JL, Hamilton JM, Kane A, Gamst AC et al. Cognitive and functional decline in Huntington's disease: dementia criteria revisited. Mov Disord 2010;25:1163-9.
76. Vaccarino AL, Sills T, Anderson KE, Bachoud-Lévi AC, Borowsky B, Craudurd D et al. Assessment of depression, anxiety and apathy in prodromal and early Huntington disease. PLoS Curr 2011;3:RRN1242.
77. Goodman AO, Rogers L, Pilsworth S, McAllister CJ, Shneerson JM, Morton AJ et al. Asymptomatic sleep abnormalities are a common early feature in patients with Huntington's disease. Curr Neurol Neurosci Rep 2011;11:211-7.
78. Goodman AO, Barker RA. How vital is sleep in Huntington's disease? J Neurol 2010;257:882-97.
79. Aziz NA, Anguelova GV, Marinus J, Lammers GJ, Roos RA. Sleep and circadian rhythm alterations correlate with depression and cognitive impairment in Huntington's disease. Parkinsonism Relat Disord 2010;16:345-50.
80. Cuturic M, Abramson RK, Vallini D, Frank EM, Shamsnia M. Sleep patterns in patients with Huntington's disease and their unaffected first-degree relatives: a brief report. Behav Sleep Med 2009;7:245-54.
81. Pallier P, Maywood E, Zheng Z, Chesham J, Inyushkin A, Dyball R et al. Pharmacological imposition of sleep slows cognitive decline and reverses dysregulation of circadian gene expression in a transgenic mouse model of Huntington's disease. J Neurosci 2007;27:7869-78. (Pubitemid 47093825)
82. Gray M, Shirasaki DI, Cepeda C, André VM, Wilburn B, Lu XH et al. Full-length human mutant huntingtin with a stable polyglutamine repeat can elicit progressive and selective neuropathogenesis in BACHD mice. J Neurosci 2008;28:6182-95.
83. Kudo T, Schroeder A, Loh DH, Kuljis D, Jordan MC, Roos KP et al. Dysfunctions in circadian behavior and physiology in mouse models of Huntington's disease. Exp Neurol 2011;228:80-90.
84. Andrich J, Schmitz T, Saft C, Pastert T, Kraus P, Epplen JT et al. Autonomie nervous system function in Huntington's disease. J Neurol Neurosurg Psychiatry 2002;72:726-31. (Pubitemid 34557013)
85. Bär KJ, Boettger MK, Andrich J, Epplen JT, Fischer F, Cordes J et al. Cadriovascular modulation upon postural change is altered in Huntington's disease. Eur J Neurol 2008;15:869-71
86. Kobal J, Meglic B, Mesec A, Peterlin B. Early sympathetic hyperactivity in Huntington's disease. Eur J Neurol 2004;11:842-8. (Pubitemid 39665063)
87. Kobal J, Melik Z, Cankar K, Bajrovic FF, Meglic B, Peterlin B, Zaletel M. Autonomic dysfunction in presymptomatic and early symptomatic Huntington's disease. Acta Neurol Scand 2010;121:392-9.
88. Bigger JT Jr, Fleiss JL, Steinman RC, Rolnitzky LM, Kleiger RE, Rottman JN. Frequency domain measures of heart period variability and mortality after myocardial infarction. Circulation 1992;85:164-71.
89. Buccelletti E, Gilardi E, Scaini E, Galiuto L, Persiani R, Biondi A et al. Heart rate variability and myocardial infarction: systemic literature review and metanalysis. Eur Rev Med Pharmacol Sci 2009;13:299-307.
90. Thayer JF, Yamamoto SS, Brosschot JF. The relationship of autonomic imbalance, heart rate variability and cardiovascular disease risk factors. Int J Cardiol 2010;141:122-31.
91. Chiu E, Alexander L. Causes of death in Huntington's disease. Med J Aust 1982;1:153.
92. Lanska DJ, Lavine L, Lanska MJ, Schoenberg BS. Huntington's disease mortality in the United States. Neurology 1988;38:769-72.
93. Carruthers SG, McCall B, Cordell BA, Wu R. Relationships between heart rate and PR interval during physiological and pharmacological interventions. Br J Clin Pharmacol 1987;23:259-65. (Pubitemid 17108185)
94. Wallick DW, Manin PJ, Masuda Y, Levy MN. Effects of autonomic activity and changes in heart rate on atrioventricular conduction. Am J Physiol 1982;243:H523-7. (Pubitemid 12001229)
95. Akita M, Kuwahara M, Tsubone H, Sugano S. ECG changes during furosemide-induced hypokalemia in the rat. J Electrocardiol 1998;31:45-9. (Pubitemid 28124245)
96. Schroeder AM, Loh DH, Jordan MC, Roos KP, Colwell CS. Baroreceptor reflex dysfunction in the BACHD mouse model of Hungtinton's disease. PLoS Curr 2011;3:RRN1266.
97. Maywood E, Fraenkel E, McAllister C, Wood N, Reddy A, Hastings M et al. Disruption of peripheral circadian timekeeping in a mouse model of Huntington's disease and its restoration by temporally scheduled feeding. J Neurosci 2010;30:10199-204.
98. Colwell CS. Linking neural activity and molecular oscillations in the SCN. Nat Rev Neurosci 2011;12:553-69.
99. Dani VS, Chang Q, Maffei A, Turrigiano GG, Jaenisch R, Nelson SB. Reduced cortical activity due to a shift in the balance between excitation and inhibition in a mouse model of Rett syndrome. Proc Natl Acad Sci USA 2005;102:12560-5. (Pubitemid 41266398)
100. Gogolla N, Leblanc JJ, Quast KB, Sudhof TC, Fagiolini M, Hensch TK. Common circuit defect of excitatory-inhibitory balance in mouse models of autism. J Neurodev Disord 2009;1:172-81.
101. Milnerwood AG, Raymond LA. Early synaptic pathophysiology in neurodegeneration: insights from Huntington's disease. Trends Neurosci 2010;33:513-23.
102. Nelson SB, Turrigiano GG. Strength through diversity. Neuron 2008;60:477-82.
103. Shepherd GM, Katz DM. Synaptic microcircuit dysfunction in genetic models of neurodevelopmental disorders: focus on Mecp2 and Met. Curr Opin Neurobiol 2011;21:827-33.
104. Cummings DM, Andre VM, Uzgil BO, Gee SM, Fisher YE, Cepeda C, Levine MS. Alterations in cortical excitation and inhibition in genetic mouse modeles of Huntington's disease. J Neurosci 2009;29:10371-86.
105. Cepeda C, Hurst RS, Calvert CR, Hernandex-Escheagaray E, Nguyen OK, Jocoy E et al. Transient and progressive electrophysiological alterations in the corticostriatal pathway in a mouse model of Huntington's disease. J Neurosci 2003;23:961-9. (Pubitemid 36206187)
106. Walker AG, Miller BR, Fritsch JN, Barton SJ, Rebec GV. Altered information processing in the prefrontal cortex of Huntington's disease mouse models. J Neurosci 2008;28:8973-82.
107. Rebec GV, Conroy SK, Barton SJ. Hyperactive striatal neurons in symptomatic Hungtinton R6/2 mice: variations with behavioral state and repeated ascorbate treatment. Neuroscience 2006;137:327-36. (Pubitemid 43031499)
108. Miller BR, Walker AG, Shah AS, Barton SJ, Rebec GV. Dysregulated information processing by medium spiny neurons in striatum of freely behaving mouse models of Huntington's disease. J Neurophysiol 2008;100:2205-16.
109. Pennartz CM, Bierlaagh MA, Geurtsen AM. Cellular mechanisms underlying spontaneous firing in rat suprachiasmatic nucleus: involvement of a slowly inactivation component of sodium current. J Neurophysiol 1997;78:1811-25. (Pubitemid 27446965)
110. Jackson AC, Yao GL, Bean BP. Mechanism of spontaneous firing in dorsomedial suprachiasmatic nucleus neurons. J Neurosci 2004;24:7985-98. (Pubitemid 39280818)
111. Kononenko NI, Medina I, Dudek FE. Persistent subthreshold voltage-dependent cation single channels in suprachiasmatic nucleus neurons. Neuroscience 2004;129:85-92. (Pubitemid 39360944)
112. Correia SC, Santos RX, Perry G, Zhu X, Moreira PI, Smith MA. Mitochondrial importance in Alzheimer's, Huntington's and Parkinson's diseases. Adv Exp Med Biol 2012;724:205-21
113. Schapira AH. Mitochondrial diseases. Lancet 2012;379:1825-34.
114. Wang YC, Huang RC. Effects of sodium pump activity on spontaneous firing in neurons of the rat suprachiasmatic nucleus. J Neurophysiol 2006;96:109-18.
115. Trushina E, Dyer RB, Badger JD 2nd, Ure D, Eide L, Tran DD et al. Mutant huntingtin impairs axonal trafficking in mammalian neurons in vivo and in vitro. Mol Cell Biol 2004;24:8195-209. (Pubitemid 39167467)
116. Shimohata T, Nakajima T, Yamada M, Uchida C, Onodera O, Naruse S et al. Expanded polyglutamine stretches interact with TAFII130, interfering with CREB-dependent transcription. Nat Genet 2000;26:29-36.
117. Sugars KL, Brown R, Cook LJ, Swartz J, Rubinsztein DC. Decreased cAMP response element-mediated transcription: an early event in exon 1 and fulllength cell models of Huntington's disease that contributes to polyglutamine pathogenesis. J Biol Chem 2004;279:4988-99. (Pubitemid 38199095)
118. Hardeland R, Coto-Montes A, Poeggeler B. Circadian rhythms, oxidative stress, and antioxidative defense mechanisms. Chronobiol Int 2003;20:921-62. (Pubitemid 37517510)
119. Antoch MP, Kondratov RV. Circadian proteins and genotoxic stress response. Circ Res 2010;106:68-78.
120. Kondratov RV, Kondratova AA, Gorbacheva VY, Vykhovanets OV, Antoch MP. Early aging and age-related pathologies in mice deficient in BMAL1, the core component of the circadian clock. Genes Dev 2006;20:1868-73. (Pubitemid 44088348)
121. Cotella D, Hernandez-Enriquez B, Wu X, Li R, Pan Z, Leveille J et al. Toxic role of K+ channel oxidation in mammalian brain. J Neurosci 2012;32:4133-44.
122. Sesti F, Liu S, Cai SQ. Oxidation of potassium channels by ROS: a general mechanism of aging and neurodegeneration. Trends Cell Biol 2010;20:45-51.
123. Hastings M, Reddy A, Maywood E. A clockwork web: circadian timing in brain and periphery, in health and disease. Nat Rev Neurosci 2003;4:649-61. (Pubitemid 37280160)
124. Reddy AB, O'Neill JS. Healthy clocks, healthy body, healthy mind. Trends Cell Biol 2010;20:36-44.
125. Takahashi J, Hong H, Ko C, McDearmon E. The genetics of mammalian circadian order and disorder: implications for physiology and disease. Nat Rev Genet 2008;9:764-75.
126. Bechtold DA, Gibbs JE, Loudon AS. Circadian dysfunction in disease. Trends Pharmacol Sci 2010;31:191-8.